"I love Impactful Medicines for Rare Neurological Disorders | Ovid Therapeutics"

2022-06-15 23:42:05

Skip to content Your browser does not support HTML5 video. menu Vision and LeadershipScience and Pipeline « Back SciencePipelineClinical StudiesPartnersCommitmentInvestors « Back NewsEvents & PresentationsStock InformationFinancialsGovernanceResourcesPeopleCareersContact Vision and LeadershipScience and Pipeline « Back SciencePipelineClinical StudiesPartnersCommitmentInvestors « Back NewsEvents & PresentationsStock InformationFinancialsGovernanceResourcesPeopleCareersContact Boldly transforming thelives of individuals with rareneurological diseases boldvision Science-driven and patient-focused, our mission is to develop medicines that transform the lives of patients with epilepsies and seizure-related disorders. Meet the leadership » boldscience Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders. Explore our exciting pipeline » boldcommitment At Ovid, we seek to understand what matters most to individuals with rare diseases and their families.  We are committed to address the challenges they face every day. Why we do what we do » press releases Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate HighlightsOvid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare ConferenceOvid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial ResultsOvid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference View all insights » boldpeople Each team member understands the difference between a drug and a medicine—one is a product, the other changes lives—and that's what brings us together as Ovidians. About us See open positions ContactPrivacy PolicyTerms & Conditions AgreementCommunity GuidelinesThird-Party Websites © Copyright 2022 Ovid Therapeutics. Ovid, Ovid Therapeutics, Ovid Therapeutics Inc.,and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved. COVID-19 update: The safety of our communities is paramount.See our ongoing response » if(typeof Object.assign!="function"){Object.assign=function(target){"use strict";if(target==null){throw new TypeError("Cannot convert undefined or null to object")}target=Object(target);for(var index=1;index